{
    "organizations": [],
    "uuid": "a38f6f74fb54a2d28607ddda8004af19ac35ff41",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-raqualia-pharma-plans-pharmaceutic/brief-raqualia-pharma-plans-pharmaceutical-jv-with-zte-coming-biotech-idUSL4N1PO2SN",
    "ord_in_thread": 0,
    "title": "BRIEF-RaQualia Pharma plans pharmaceutical JV with ZTE Coming Biotech",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 29(Reuters) - RaQualia Pharma Inc\n* Says it plans to set up a JV, which will be engaged in research and development of pharmaceutical, with Shanghai-based firm ZTE Coming Biotech Co., Ltd, in May\n* Says the company and ZTE Coming Biotech will hold a 35 percent stake and a 65 percent stake in the JV respectively\nSource text in Japanese: goo.gl/mB6hEz\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-01-29T15:43:00.000+02:00",
    "crawled": "2018-01-30T19:09:16.003+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "raqualia",
        "pharma",
        "inc",
        "say",
        "plan",
        "set",
        "jv",
        "engaged",
        "research",
        "development",
        "pharmaceutical",
        "firm",
        "zte",
        "coming",
        "biotech",
        "ltd",
        "may",
        "say",
        "company",
        "zte",
        "coming",
        "biotech",
        "hold",
        "percent",
        "stake",
        "percent",
        "stake",
        "jv",
        "respectively",
        "source",
        "text",
        "japanese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}